title: Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany.
authors.affiliation: Praxisklinik am Rosengarten, Mannheim, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Diel
authors.affiliation: Amgen GmbH, Munich, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Ikenberg
authors.affiliation: Amgen (Europe) GmbH, Zug, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Cristino
authors.affiliation: Amgen (Europe) GmbH, Zug, Switzerland.
authors.forename: F
authors.initials: F
authors.lastname: Gatta
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Qian
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Arellano